➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Express Scripts
AstraZeneca
McKesson

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

IMODIUM A-D EZ CHEWS Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Imodium A-d Ez Chews patents expire, and what generic alternatives are available?

Imodium A-d Ez Chews is a drug marketed by J And J Consumer Inc and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in IMODIUM A-D EZ CHEWS is loperamide hydrochloride. There are eleven drug master file entries for this compound. Ninety-nine suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride profile page.

Drug patent expirations by year for IMODIUM A-D EZ CHEWS
Recent Clinical Trials for IMODIUM A-D EZ CHEWS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Naia PharmaceuticalsPhase 1/Phase 2
McNeil ABPhase 1
Centre de recherche du Centre hospitalier universitaire de SherbrookePhase 1/Phase 2

See all IMODIUM A-D EZ CHEWS clinical trials

US Patents and Regulatory Information for IMODIUM A-D EZ CHEWS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for IMODIUM A-D EZ CHEWS

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0428296 SPC/GB98/013 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Express Scripts
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.